Antibodies, Anti-Idiotypic
"Antibodies, Anti-Idiotypic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
| Descriptor ID |
D000888
|
| MeSH Number(s) |
D12.776.124.486.485.114.071 D12.776.124.790.651.114.071 D12.776.377.715.548.114.071
|
| Concept/Terms |
Antibodies, Anti-Idiotypic- Antibodies, Anti-Idiotypic
- Anti-Idiotypic Antibodies
- Antibodies, Anti Idiotypic
- Anti-Idiotype Antibodies
- Anti Idiotype Antibodies
- Antibodies, Anti-Idiotype
Anti-Antibodies- Anti-Antibodies
- Antiglobulins
- Antigamma Globulin Antibodies
- Antibodies, Antigamma Globulin
- Globulin Antibodies, Antigamma
- Anti Antibodies
- Antibodies, Anti
- Anti-gamma Globulin Antibodies
- Anti gamma Globulin Antibodies
- Antibodies, Anti-gamma Globulin
- Globulin Antibodies, Anti-gamma
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anti-Idiotypic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anti-Idiotypic".
This graph shows the total number of publications written about "Antibodies, Anti-Idiotypic" by people in this website by year, and whether "Antibodies, Anti-Idiotypic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2017 | 5 | 4 | 9 |
| 2018 | 4 | 4 | 8 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Anti-Idiotypic" by people in Profiles.
-
Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection. Ann Clin Biochem. 2021 11; 58(6):614-621.
-
One-pot pre-coated interface proximity extension assay for ultrasensitive co-detection of anti-SARS-CoV-2 antibodies and viral RNA. Biosens Bioelectron. 2021 Dec 01; 193:113535.
-
Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease. PLoS Pathog. 2020 08; 16(8):e1008735.
-
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol. 2020 Jul; 84:106560.
-
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 04 23; 382(17):e38.
-
Ligelizumab for Chronic Spontaneous Urticaria. N Engl J Med. 2019 10 03; 381(14):1321-1332.
-
Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes. Indian J Med Res. 2019 Jan; 149(1):18-25.
-
New biologics in the treatment of urticaria. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):425-431.
-
Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA. Transfusion. 2018 10; 58(10):2320-2325.
-
Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure. J Am Soc Nephrol. 2018 09; 29(9):2279-2285.